Shire
SHP
Delayed London Stock Exchange - 09/20 05:35:17 pm
4509GBp
-0.52%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Develops and markets medicines for patients with rare diseases

Shire Plc is a biopharmaceutical company.

It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs.

The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol.

Shire was founded in 1986 and is headquartered in Dublin, Ireland.
Managers
Name Title
Susan Saltzbart Kilsby Non-Executive Chairman
Thomas J. W. Dittrich Chief Financial Officer & Director
Howard Mayer Chief Medical Officer
Matthew Walker Head-Technical Operations
Andreas Eugen Busch Chief Scientific Officer
Steven H. Gillis Independent Non-Executive Director
Sara Mathew Independent Non-Executive Director
Albert P. L. Stroucken Independent Non-Executive Director
Gail D. Fosler Independent Non-Executive Director
Ian T. Clark Independent Non-Executive Director
Shareholders
Name Equities %
Glenview Capital Management LLC 4,961,899 1.63%
Adage Capital Management LP 3,200,000 1.05%
Paulson & Co., Inc. 2,802,200 0.92%
T. Rowe Price Associates, Inc. 1,955,356 0.64%
Sachem Head Capital Management LP 1,910,807 0.63%
Davis Selected Advisers LP 1,864,875 0.61%
Henderson Global Investors Ltd. 1,700,413 0.56%
Davis Selected Advisers - NY, Inc. 1,591,550 0.52%
Maverick Capital Ltd. 1,469,786 0.48%
The Vanguard Group, Inc. 1,342,445 0.44%
Company contact information
22 Grenville Street
JE4 8PX St. Helier, Jersey, Channel Islands
United Kingdom

Phone : +44 (0)12 56 894 160
Fax : +44
Internet : http://www.shire.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, Nasdaq 100, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  JE00B2QKY057
- Bloomberg Code :  SHP
- Reuters Code :  SHP.L
- Datastream Code :  SHP
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
SHIRE15.62%54 502
JOHNSON & JOHNSON0.59%376 820
PFIZER20.13%253 595
NOVARTIS-0.80%216 184
ROCHE HOLDING LTD.-4.06%211 637
MERCK AND COMPANY24.36%186 114
AMGEN16.35%131 526
ABBOTT LABORATORIES19.87%120 171
ELI LILLY AND COMPANY26.55%113 563
SANOFI4.55%109 834
BRISTOL-MYERS SQUIBB COMPANY0.33%99 218
GLAXOSMITHKLINE13.18%97 628
ASTRAZENECA9.37%93 281
NOVO NORDISK A/S-10.27%89 874
BAYER-27.67%80 647
ALLERGAN PLC13.75%63 826
CELGENE CORPORATION-16.05%61 460
ASTELLAS PHARMA INC38.69%35 399
CHUGAI PHARMACEUTICAL CO LTD21.84%34 812
TAKEDA PHARMACEUTICAL CO LTD-27.49%33 184
JIANGSU HENGRUI MEDICINE CO LTD11.47%31 799